The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 0.78 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M -2.79 — no flag raisedOK
- Earnings quality 85/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as Sotera Health Co reports it. History and quarterly detail are in the app.
- Sterigenics$755.8M
- Nelson Labs$220.2M
- Nordion$187.6M
Leadership changes
From Sotera Health Co's own filings, the day they're filed.
- Kenneth D. Krause · director · appointmenteff. 2026-03-16
- Constantine S. Mihas · director · departureeff. 2026-03-16
- David A. Donnini · director · departureeff. 2024-09-06
Latest filings
- 8-K · Company announcement2026-08-14
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-08-06
- 8-K · Company announcement2026-05-22
- 8-K · Company announcement2026-05-20
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Sotera Health Co, every answer cited to the official filings🔒
- The Intelligence Brief — added when Sotera Health Co's brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.